Praxis terminates $125M ATM equity facility with Jefferies; had raised $42.7M

Praxis Precision Medicines, Inc.

Terminated Open Market Sale Agreement with Jefferies on June 15, 2023; effective after 10 trading days.
Facility allowed sales of up to $125M; company had sold 18,279,207 shares for $42.7M gross proceeds.
No termination penalties; termination is at the company's discretion per Section 7(b).

item 1.02

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Praxis Precision Medicines, Inc. terminated Open Market Sale Agreement with Jefferies LLC (effective 2023-06-15).

Action: termination
Agreement: atm program
Counterparty: Jefferies LLC
Effective: 2023-06-15

Exact text from the filing

On June 15, 2023, the Company delivered written notice to Jefferies to terminate the Sales Agreement pursuant to Section 7(b) thereof.

View on SEC.gov

Browse all material agreements →

Praxis Precision Medicines, Inc. filing history →

Source: SEC EDGAR

accession 0001689548-23-000113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.